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Para-Bombay is a rare phenotype with a homozygous nonfunc-
tional FUT1 gene and a normal FUT2 gene leading to H-deficient 
red blood cells (RBCs) with or without ABH substances, 
depending on inheritance of the ABO gene. This case is about a 
5-day-old male baby suffering from sepsis who required a 45-mL 
packed RBC transfusion. The baby’s sample tested as A1B, D+ and 
mother’s sample tested as group O, D+ with group 4 discrepancy 
due to ABO isoagglutinins. Further workup of the mother’s sample 
with anti-H lectin was negative, which suggested the mother to be 
group Oh, D+. Antibody screening was panreactive with negative 
autocontrol, suggestive of anti-H. The titer of immunoglobulin 
(Ig)M anti-H was 64, IgG titer using dithiothreitol was 8, and anti-
IH was absent. A negative adsorption and elution test suggested that 
RBCs were devoid of A and B antigens. The father’s sample tested 
clearly as group A1, D+; hence, the cis-AB blood group was ruled 
out in the baby. The secretor study of the mother’s saliva revealed 
the presence of B and H substances that neutralized polyclonal B 
and H antisera. Therefore, we concluded that the mother was of the 
para-Bombay (Bh) phenotype. This case highlights the importance 
of reverse grouping and resolving blood grouping discrepancies 
between mother and child―in this case because of an incongruous 
ABO blood type of the baby and the mother who was previously 
tested as group O, D+. Immunohematology 2021;37:59–63. 
DOI:10.21307/immunohematology-2021-008.
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The Bombay phenotype was identified in 1952 by 
Bhende and colleagues.1 The Bombay phenotype results 
from a homozygous deficiency of the FUT1 gene along with 
a silenced mutation of the FUT2 gene. The incidence of the 
Bombay phenotype in the Indian population is approximately 
1 in 10,000 and is most often due to a T725G mutation in the 
FUT1 gene and a 10-kb deletion in the FUT2 gene.2 The para-
Bombay phenotype is either due to a point mutation or a silence 
mutation on the FUT1 gene with a normal FUT2 gene.2 As a 
result, para-Bombay individuals have ABH substances in their 
secretions and plasma (Type 1 precursor chain) depending 
on whether or not they inherit ABO genes. ABH substance in 
the plasma can be adsorbed onto the red blood cells (RBCs), 
leading to a weak expression of ABH antigens. There are few 
case reports on the para-Bombay phenotype from India; what 
makes this case unique is that we identified a para-Bombay 
phenotype in the mother because of her newborn’s blood type.
Case Report
We received a request for 45-mL packed red blood cell 
(PRBC) concentrate for a neonate on postnatal day 7 who 
was diagnosed with sepsis. The male baby was born after 
a full-term normal delivery (weight 2300 g) at an outside 
hospital and had been transferred to our center because of 
suspected sepsis, later confirmed as Klebsiella pneumoniae 
sepsis, on postnatal day 6. We performed blood grouping on 
AutoVue Innova (Ortho Clinical Diagnostics, Raritan, NJ) 
using column agglutination technology per departmental 
standard protocol. The direct antiglobulin test (DAT) of the 
baby (Fig. 1A) as well as the mother’s ABO grouping were 
obtained (Table 1). The mother’s ABO grouping showed an 
unexpected reaction in the pooled O RBC suspension on 
serum testing, which led us to suspect a group 4 discrepancy 
(defined as an unexpected reaction in pooled RBCs because of 
ABO isoagglutinins or unexpected non-ABO alloantibodies),3 
and hence anti-H lectin (Tulip Diagnostics, Goa, India) 
as well as indirect agglutination testing was performed to 
resolve the discrepancy. Antibody screening and identification 
showed panagglutination reactivity (Fig. 1B–D) with negative 
autocontrol (Bio-Rad, Hercules, CA); additional testing with 
anti-H lectin was negative, thus implying the mother’s blood 
group/type to be Oh D+. The antibody reacted strongly with 
cord group O RBCs (4+), similar to its reactivity with adult 
group O RBCs, thus ruling out anti-IH. However, we were not 
able to perform a complete adsorption of the suspected anti-H 
and repeat the antibody identification to rule out other clinically 
significant antibodies due to the limited sample volume. Also, 
due to lack of H-deficient RBCs, we were not able to confirm 
the antibody specificity, thus concluding the antibody to be a 
‘probable anti-H’. The antibody titer by serial dilution using 
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conventional tube method showed 64 in immediate spin phase 
(immunoglobulin [Ig]M) and 8 after dithiothreitol (DTT) 
treatment of serum in the antihuman globulin (AHG) phase 
using anti-IgG (Tulip Diagnostics). All workup was done after 
obtaining informed consent from the parents.
The mother was a primigravida; she had a normal vaginal 
delivery at 36 weeks of gestation with no history of previous 
transfusions. Her sample was tested as group O, D+ in the 
referring hospital. Because the mother was Oh and baby was 
A1B, we considered the possibility of a cis-AB blood group, 
and hence we performed blood testing of the father—he was 
group A1, D+ (Table 1). A thorough history from the parents 
was obtained; this information ruled out in vitro fertilization/
assisted reproductive methods and the possibility of another 
biological father. The other possibility was the mother being of 
the para-Bombay phenotype with offspring inheriting the ABO 
gene. We collected saliva samples and performed the secretor 
test per the method given by AABB.4 The test revealed that the 
mother had B and H substances in her saliva that neutralized 
polyclonal B and H antisera (Table 2). This finding was further 
Table 1. Blood group testing results of the neonate, mother, and father
Anti-A Anti-A1 Anti-B Anti-A,B Anti-D1
† Anti-D2† Anti-H A RBCs* B RBCs* O RBCs* Inference
Neonate +4 +4 +4 +4 +4 +4 +2 — — — A1B, D+
Mother 0 0 0 0 +4 +4 0 +4 +4 +4 ? Bombay
? AlloAb
Father +4 +4 0 +4 +4 +4 +4 0 +4 0 A1, D+
*Pooled red blood cell (RBC) suspensions, prepared in-house. 
†D1 and D2 denote D typing reagents from two different lots as per departmental standard operating procedure.
Fig. 1 Direct antiglobulin test of the baby depicted by arrow (A); antibody screening (B) and identification (C, D) of the mother was performed 
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Probable anti-H in an H-deficient Bh para-Bombay mother
supported by the Lewis phenotype of the mother, Le(a–b+), 
which suggested that she is a secretor. These findings led to 
the determination of the mother to be an H-deficient secretor, 
probably Bh (para-Bombay), D+ phenotype.
All the crossmatched PRBC units were incompatible 
with the mother’s serum; hence, we crossmatched with the 
baby’s serum. A PRBC unit (group O, D+) that was ABO-
compatible and AHG phase crossmatch–compatible with the 
baby’s serum was issued, and the post-transfusion increase 
in hemoglobin and hematocrit was sufficiently achieved. 
The laboratory parameters before and after transfusion are 
provided in Table 3. The transfusion event was uneventful. 
The parents were counseled regarding the rare para-Bombay 
phenotype in the mother.
Discussion
The possible mechanisms of the para-Bombay phenotype 
are a mutated or a silenced FUT1 gene (H gene) with an active 
FUT2 gene (secretor SE gene), resulting in expressing ABH 
substances in secretions.2 These individuals are homozygous 
for a nonfunctional FUT1 gene. The common mutations 
in FUT1 and FUT2 genes in a para-Bombay phenotype 
identified in recent years are summarized in Table 4. These 
individuals may express weak ABH substances on their RBCs 
by adsorbing a Type 1 precursor chain from the plasma. The 
negative results in the adsorption and elution in our case 
suggested that the RBCs were devoid of antigen expression. 
During the secretor status workup in this case, the anti-B and 
anti-H were neutralized by B and H substances, respectively, 
whereas anti-A was not inhibited. The immunohematologic 
workup concluded that the mother was an H-deficient secretor 
for B and H substances with probable anti-H, and she lacked 
antigen expression on RBCs, making a possible serologic 
conclusion of the Bh para-Bombay secretor phenotype. 
Phenotyping the mother for Lewis antigens gave the result 
of Le(a–b+), also revealing that the mother has the secretor 
gene—because the Lewis phenotype of nonsecretors would 
be Le(a+b–), since they lack the Se allele needed for the 
conversion of Type 1 precursor to Type 1H precursor, which is 
then converted to Leb antigen by the LE gene.
Anti-H found in a Bombay individual is a clinically 
significant antibody causing hemolytic transfusion reactions 
Table 2. Secretor status workup
Blood group/ 
D type
Anti-A +  
A RBCs*
Anti-B +  
B RBCs*




A, D+ 0 2+ 0 Group A
Known 
secretor 2
B, D+ 2+ 0 0 Group B
Mother 
(patient)
? Oh, D+ 2+ 0 0 Bh para-Bombay
Nonsecretor O, D+ 2+ 2+ 2+ Nonsecretor
Saline NA 2+ 2+ 2+ No substances
* Pooled red blood cell (RBC) suspensions, prepared in-house.  
NA = not applicable.
Table 3. Laboratory parameters of the newborn 
Parameters (normal lab range) Admission (PND 4) Before transfusion (PND 6) 24 hours after transfusion (PND 8)
Hemoglobin (14–22 g/dL) 11.4 9.8 11.1
Hematocrit (45–75%) 32.6 26 32.1
RBC count (5–7 × 106/µL) 3.84 2.81 3.61
Reticulocyte (2–5%) 4.8 0.76 1.86
Reticulocyte absolute (0.02–0.11 × 106/µL) 0.06 0.02 0.07
Platelet (100–400 × 103/µL) 151 118 138
Total leukocyte count (10–26 × 103/µL) 4.5 14.6 15.5
Total bilirubin (≤8 mg/dL) 8.9 5.4 2.09
Direct bilirubin (0–0.6 mg/dL) 0.9 1.1 1.0
C-reactive protein (0–5 mg/L) 24.8 19.9 8.59






pH 7.27 — —
sO2 (92–94%) 87 — —
PND = postnatal day; RBC = red blood cell; nRBCs = nucleated red blood cells; sO2 = saturated oxygen. 
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and hemolytic disease of the fetus and newborn (HDFN). It 
is predominantly of the IgM type that reacts at 4–37°C and 
agglutinates all reagent RBCs.22 Compared with the anti-H 
in the Bombay phenotype, anti-H found in para-Bombay is a 
weaker antibody with lower titers, whereas anti-IH, a complex 
antibody, is also found in rare hh individuals. In our case, 
the possibility of anti-IH was ruled out because of the strong 
reaction with cord group O RBCs. The baby did not have 
laboratory findings characteristic of HDFN during the hospital 
stay (Table 3). The IgM type of the antibody in the mother, 
a weaker anti-H in para-Bombay individuals compared with 
Bombay individuals, and the fact that the baby’s sample tested 
as A1B (which has the least amount of H substance) played a 
role in determining the clinical significance of this probable 
anti-H and a lack of HDFN in the neonate.22,23 Para-Bombay 
individuals can have anti-H, anti-IH, or both, as well as anti-A 
or anti-B depending on their ABO group.6
In this case, the father was group A, D+, meaning that 
the father had at least one dominant A and H gene (AA/AO 
and HH/Hh). The mother was identified as Bh, having at least 
one B gene (BB/BO and hh). The baby was A1B, D+, meaning 
the A and H dominant genes came from the father and the 
dominant B gene came from the mother—thus enabling him 
to express ABH substance on his RBCs. Because the family 
members refused any further testing, we could not perform 
the genotyping of the mother. The baby’s RBC testing (A1B, 
D+) led to the identification of the mother, who was previously 
typed as group O, D+, as para-Bombay (Bh, D+). This finding 
highlights the importance of performing serologic grouping 
and investigating incongruous results, a basic step in any 
immunohematology laboratory.
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